| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PAYS | Common Stock | Options Exercise | $98,000 | +40,000 | +44% | $2.45 | 130,052 | 31 Oct 2022 | Direct | F1 |
| transaction | PAYS | Common Stock | Sale | $38,283 | -16,201 | -12% | $2.36 | 113,851 | 02 Nov 2022 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PAYS | Stock Grant | Options Exercise | +40,000 | 40,000 | 31 Oct 2022 | Common Stock | Direct | F1 |
| Id | Content |
|---|---|
| F1 | On October 22, 2018, the reporting person received a grant of 200,000 shares of common stock vesting annually in equal amounts over a five-year period commencing on October 31, 2019. As of the date of this filing, 160,000 shares of common stock have vested and been issued. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.31 to $2.40, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | These shares of common stock were sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |